Nobel committee honors tumor immunologists

This commentary wishes to highlight the 2018 Nobel Prize in Medicine awarded to two cancer immunotherapy scientists, Prof James Allison and Prof Tasuku Honjo, for their discovery on unleashing the body’s immune system to attack cancer. Their studies have led to the development of an entire class of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotte, Anand, D’Orazi, Gabriella, Bhandaru, Madhuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206712/
https://www.ncbi.nlm.nih.gov/pubmed/30376854
http://dx.doi.org/10.1186/s13046-018-0937-6
_version_ 1783366405161222144
author Rotte, Anand
D’Orazi, Gabriella
Bhandaru, Madhuri
author_facet Rotte, Anand
D’Orazi, Gabriella
Bhandaru, Madhuri
author_sort Rotte, Anand
collection PubMed
description This commentary wishes to highlight the 2018 Nobel Prize in Medicine awarded to two cancer immunotherapy scientists, Prof James Allison and Prof Tasuku Honjo, for their discovery on unleashing the body’s immune system to attack cancer. Their studies have led to the development of an entire class of drugs that hopefully will bring lasting remissions to many patients who had run out of options.
format Online
Article
Text
id pubmed-6206712
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62067122018-10-31 Nobel committee honors tumor immunologists Rotte, Anand D’Orazi, Gabriella Bhandaru, Madhuri J Exp Clin Cancer Res Commentary This commentary wishes to highlight the 2018 Nobel Prize in Medicine awarded to two cancer immunotherapy scientists, Prof James Allison and Prof Tasuku Honjo, for their discovery on unleashing the body’s immune system to attack cancer. Their studies have led to the development of an entire class of drugs that hopefully will bring lasting remissions to many patients who had run out of options. BioMed Central 2018-10-30 /pmc/articles/PMC6206712/ /pubmed/30376854 http://dx.doi.org/10.1186/s13046-018-0937-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Rotte, Anand
D’Orazi, Gabriella
Bhandaru, Madhuri
Nobel committee honors tumor immunologists
title Nobel committee honors tumor immunologists
title_full Nobel committee honors tumor immunologists
title_fullStr Nobel committee honors tumor immunologists
title_full_unstemmed Nobel committee honors tumor immunologists
title_short Nobel committee honors tumor immunologists
title_sort nobel committee honors tumor immunologists
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206712/
https://www.ncbi.nlm.nih.gov/pubmed/30376854
http://dx.doi.org/10.1186/s13046-018-0937-6
work_keys_str_mv AT rotteanand nobelcommitteehonorstumorimmunologists
AT dorazigabriella nobelcommitteehonorstumorimmunologists
AT bhandarumadhuri nobelcommitteehonorstumorimmunologists

Ejemplares similares